Ecog-acrin Cancer Research Group
Clinical trials sponsored by Ecog-acrin Cancer Research Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New MRI technique could sharpen prostate cancer staging Results expected Dec 2026 (estimated)
- New drug combos tested to improve lymphoma control in younger patients Results expected Dec 2026 (estimated)
- Massive myeloma trial tests which combo works best Results expected Dec 2026 (estimated)
- Green tea extract tested to keep prostate cancer in check Results expected Dec 2026 (estimated)
- PET scans may let melanoma patients stop treatment sooner Results expected Jan 2027 (estimated)